Waitaki bone product to grow sales in Europe
New Zealand's Waitaki Biosciences is expand its presence in Europe with its flagship MCH-Cal bone health ingredient, and is looking at ways to diversify by tapping the country's non-animal resources.
New Zealand's Waitaki Biosciences is expand its presence in Europe with its flagship MCH-Cal bone health ingredient, and is looking at ways to diversify by tapping the country's non-animal resources.
Martek Biosciences has signed a license agreement that enables Medici Medical to use its DHA and ARA in infant formulas sold in Israel.
New research challenges current WHO advice for routine iron and folic acid supplements for kids in areas endemic with malaria.
Food safety fears have led to the emergence a new market in vegetarian supplement ingredients, and industry insiders predicting that as many as half of all ingredients could be non-animal derived in the next ten years.